Barclays reported a 4.23% stake in Myriad Genetics MYGN · 3,939,238 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.23%
Last report: 5.31% · filed 25/08/12
Shares held: 3,939,238 sh
Class: COMMON-STOCK
Stock: Myriad Genetics MYGN
Holder: Barclays
Event date: 25/09/30
Filed: 25/11/12

4.23% stake · below 5%

Stake: 4.23%
Last report: 5.31%
Since last report: −1.1pp

Myriad Genetics trades, last 26 weeks

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Barclays's other 5% stake reports

Barclays
5% stakeQVC Group
5% stake
QVC Group
QVCG
3.36% stake
1,681,369 sh
3.36% stake
Filed 09/08
Barclays
5% stakeQVC Group
5% stake
QVC Group
QVCG
10.21% stake
5,106,642 sh
10.21% stake
Filed 09/08
Barclays
5% stakeRising Dragon Acquisition
5% stake
Rising Dragon Acquisition
RDAC
6.74% stake
273,125 sh
6.74% stake
Filed 08/14
Barclays
5% stakeReviva Pharmaceuticals Holdings
5% stake
Reviva Pharmaceuticals Holdings
RVPH
0% stake
20 sh
0% stake
Filed 08/13
Barclays
5% stakeTavia Acquisition
5% stake
Tavia Acquisition
TAVI
0.17% stake
15,654 sh
0.17% stake
Filed 08/13